Clinicians who do prescribe AOD-9604 in this age group under a documented informed-consent framework should, at minimum, measure standing height and sitting height every 3 months, track height velocity against population norms, assess Tanner stage at each visit, and obtain fasting IGF-1 and IGFBP-3 levels at baseline and every 3 months [18]
A couple of studies found no benefits of B12 for lowering homocysteine in HD patients, one used oral B12, 2000 g three times per week for 6 weeks, 55 the other used methyl-B12 i.m
These changes appear repeatedly in structured trials
Adjusting Frequency Based on Response The dose frequency might change based on how a patient responds
Supplementing through injections can help balance mood-regulating hormones and support emotional well-being
What they did: Multiple preclinical models (mice, rats) evaluated the combination AOD-9604 + GLP-1 agonist (Semaglutide or Liraglutide)